Kodiak Sciences (KOD) Interest Expenses (2017 - 2026)
Kodiak Sciences (KOD) posted Interest Expenses of $464.4 million for Q1 2026, up 41.47% on a QoQ basis from $328.3 million in Q4 2025, and up 24381.44% year-over-year from N/an in Q1 2025.
Kodiak Sciences (KOD) Interest Expenses (2017 - 2026) Analysis & Trends
Kodiak Sciences' Interest Expenses history runs 10 years deep, the most recent figure standing at $464.4 million for Q1 2026.
- Quarterly Interest Expenses rose 24381.44% year-over-year to $464.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $464.4 million (up 24381.44% YoY) and the FY2025 annual result came in at $328.3 million, up 32.79% from the prior year.
- Interest Expenses was $464.4 million for Q1 2026 at Kodiak Sciences, up from $328.3 million in the prior quarter.
- Across five years, Interest Expenses topped out at $464.4 million in Q1 2026 and bottomed at $4000.0 in Q4 2022.
- A 5-year average of $58.9 million and a median of $3.5 million in 2023 frame the typical range for Interest Expenses.
- Annual changes were most pronounced in 2022 — Interest Expenses slumped 98.91% — and 2025, when it soared 36375.78%.
- Kodiak Sciences' Interest Expenses stood at $4000.0 in 2022, then soared by 22075.0% to $887000.0 in 2023, then grew by 1.47% to $900000.0 in 2024, then surged by 36375.78% to $328.3 million in 2025, then surged by 41.47% to $464.4 million in 2026.
- Business Quant data shows KOD's Interest Expenses at $464.4 million in Q1 2026, $328.3 million in Q4 2025, and $166.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -42,141.15 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 32.89 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 16.81 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 420.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 28.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.17 Bn |
| 10 | Kodiak Sciences | 2.54 Bn | 2.54 Bn | - | 464.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 464.41 Mn |
| Mar 31, 2026 | 464.41 Mn |
| Dec 31, 2025 | 328.28 Mn |
| Dec 31, 2025 | 328.28 Mn |
| Sep 30, 2025 | 166.58 Mn |
| Sep 30, 2025 | 166.58 Mn |
| Jun 30, 2025 | 5.77 Mn |
| Jun 30, 2025 | 5.77 Mn |
| Mar 31, 2025 | 1.90 Mn |
| Mar 31, 2025 | 1.90 Mn |
| Dec 31, 2024 | 900,000.00 |
| Dec 31, 2024 | 900,000.00 |
| Sep 30, 2024 | 1.19 Mn |
| Sep 30, 2024 | 1.19 Mn |
| Jun 30, 2024 | 594,000.00 |
| Jun 30, 2024 | 594,000.00 |
| Mar 31, 2024 | 2.07 Mn |
| Mar 31, 2024 | 2.07 Mn |
| Dec 31, 2023 | 887,000.00 |
| Dec 31, 2023 | 887,000.00 |